Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells - Test2 - elhamkhani - TriplyDB

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

http://www.wikidata.org/entity/Q28214426

about

sameAs

White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenases A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression PPARγ as a Novel Therapeutic Target in Lung Cancer Identification of nesfatin-1 as a satiety molecule in the hypothalamus Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.Obesity and cancer--mechanisms underlying tumour progression and recurrence Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer Peroxisome proliferator-activated receptors and cancer: challenges and opportunities Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Function of PPARgamma and its ligands in lung cancer.Peroxisome proliferator-activated receptors in lung cancer.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer Peroxisome proliferator-activated receptors and progression of colorectal cancer.PPARgamma and Apoptosis in Cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.Thiazolidinediones as anti-cancer agents.Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.Peroxisome proliferator-activated receptor γ and colorectal cancer.Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.Insights into the Link Between Obesity and Cancer.New molecular insights in tobacco-induced lung cancer.Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening.Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung Cancer PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2.3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population.Genotoxic investigation of a thiazolidinedione PPARγ agonist using the in vitro micronucleus test and the in vivo homozygotization assay.Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.

P2860

Q24618321-82727962-264C-4CD0-9A7B-AC338BA4D4CF Q24631506-487D806B-7AB2-47F6-8A35-51FE0CAB7463 Q28068114-AD8B9B3F-9BC3-4A28-B078-BBB3E1C6FB53 Q28268139-CB81BA08-B286-4B77-9083-A0BED8A03317 Q33837550-7FA0768D-71FE-41D7-B125-8C9DE496F301 Q34235817-D2088FCB-F50B-4FB5-B12E-1B4C97CAAED3 Q34425077-4B4CD4FC-1BBD-40C5-B77A-CB60908EE0E9 Q34878637-76A02073-9C6C-49EF-B1E2-1EAA63F30C14 Q35210023-64A39730-AF6E-4314-B08A-2453C429B6C9 Q36162095-A36247C1-0A35-41FA-BAD9-0E2E1283E568 Q36182783-3E352E45-8E66-47A0-B776-BE1BE45D2CF0 Q36328530-3A3CAEAE-7BBC-4FB4-8E1B-74FA9884E288 Q36414175-9AF2BF3D-9491-4D42-B216-348D455CCEA9 Q36417658-005BB501-FE19-4E99-B74C-2BD30D2F4B78 Q36661722-6D141E73-D494-4275-A4F9-48792D6C902C Q36710291-D6C20D88-77FE-470B-AE6A-3614B1CD224A Q36742811-807E1C24-8A0E-4ADE-BA6A-BB92F917EB9B Q36836697-7777CF8E-361D-49C7-BD71-6209990F2E86 Q37010188-D3629E7B-7012-41C6-864C-9E486F278CC6 Q37188588-AC806963-42C5-49CC-8CF8-CD40E04A5D3E Q37821269-58B54161-2C38-4886-8BC7-258D173AD0AD Q37847515-72C67C32-AB6C-4854-AAD9-D576E2E66A38 Q38359904-565AECC4-91EB-48B5-931C-84BE196FCD54 Q38641190-1C9ABA3F-DF72-4207-A196-3A0ABBE4EED4 Q38986353-E7F19B0C-0BCD-43B2-97B4-BEFD5E723E42 Q39256853-DFDC1AC5-2F42-40EA-A9FD-528DFD26F8EE Q39424261-5075690C-DBF5-4983-A9C7-519506F29417 Q39581456-4ABE9CB1-D7A9-4B1A-B0BE-142E9E799087 Q40295334-30E90038-9789-4CA1-9355-1667852CA99B Q42126506-8B70B2F4-B2F1-4DED-8926-9F43685B6586 Q42250957-7670964F-CAA4-48DB-9659-C06E59A476B3 Q42419278-C0DD5724-7480-44F6-B6A9-CACD0B81C45A Q42745788-AC75BB2C-B563-43C7-9273-9B044F1A707B Q42830687-652335FA-1994-4FA2-9F2A-A0F16CC158DE Q43443193-E6E9BCBD-08B4-4635-A788-98D58A52462E Q46603087-12B92FA5-649B-41D4-B182-9F11F7970F25 Q53060957-EE33E950-96C1-468D-B1EA-9C9973D4F857 Q53286031-5D7588AD-452B-492F-92E3-52CD3873FA8B

P2860

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

http://www.wikidata.org/entity/Q28214426

description

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2002

@ast

im März 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 28 March 2002)

@en

vedecký článok (publikovaný 2002/03/28)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd op 2002/03/28)

@nl

наукова стаття, опублікована в березні 2002

@uk

مقالة علمية (نشرت في 28-3-2002)

@ar

name

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@ast

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@en

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@nl

type

label

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@ast

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@en

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@nl

prefLabel

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@ast

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@en

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@nl

P1433

Q28214426-DD318190-3474-4783-951F-E0C93F25C56D

P1476

Q28214426-2D3B2635-AE2D-4E39-A74F-550A5D529B1E

P2093

Q28214426-00DA0403-831D-4C7F-A550-F9B17B98E2FB

Q28214426-35809DE6-3AEC-4B17-819E-D3B390F0C745

Q28214426-37606964-83EA-4965-B323-FE8000E7A95C

Q28214426-5631BCE8-65CD-4FB6-86AE-2506314C9F0B

Q28214426-5AA19690-1C8B-4E48-8DD8-C8423DDE1C34

Q28214426-B39F57B7-F168-499D-B77E-7CA8345CF829

Q28214426-B661A2EC-4F61-49D8-B5F1-3FC6BCC449BF

Q28214426-EDCC92FA-A785-4B16-90E6-F6F0E98F755C

Q28214426-EF988D68-C9D5-40EC-8030-2F36525C85AB

Q28214426-F32979C1-EFD9-4438-B269-1D15045B1493

P2860

Q28214426-008C7342-8559-4152-954A-AAAFE2F47613

Q28214426-01C73C54-CCBC-47E2-A75E-9581B92F8E1D

Q28214426-0327B4C7-C98A-4954-B015-D5C3FF192BFE

Q28214426-0353EC74-2EB0-476B-8215-C7A2F1A7CC3C

Q28214426-0F5C9219-50F8-440B-BFF3-F95FF71BA738

Q28214426-200DE793-2CE9-4DF7-B1E4-3C341A769624

Q28214426-22308981-8FBA-48B5-961B-FF30F6E5DFCB

Q28214426-25C183E7-C060-412D-916D-F9E6312B500E

Q28214426-2BA6E2B2-2C8F-48E4-997A-0703572AEE04

Q28214426-30BA55E2-A6F0-4E27-979D-452A15A9F649

P2888

Q28214426-2F602B9C-7B27-490C-A4CC-016FB19F892A

P304

Q28214426-09C86B23-50D7-4DC5-A52B-9644515C3D2F

P31

Q28214426-B8BEBD1F-1832-4764-B250-479D35352782

P3181

Q28214426-85D3FE56-BC6B-44BC-B58D-DFC57449186A

P356

Q28214426-D8DCCBBD-80B3-4E25-A529-B87135470CA8

P407

Q28214426-8E22DE90-CC37-4F15-95E7-EA026342287B

P433

Q28214426-8EED32A2-E20D-46EE-A3E8-1146E2BCFC4D

P478

Q28214426-4476150C-74B3-46BB-874F-013B77F8E7FD

P577

Q28214426-4C07D144-438F-456D-82BE-31EA4A9DE8DF

P5875

Q28214426-0E8AE9CF-DD95-4B91-A467-3C19FB8EDCD4

P6179

Q28214426-AB26F9EF-F8EA-4C6D-BDC6-095EAD83232F

P698

Q28214426-394117E9-4CEC-4E41-A763-5FED1133F099

P921

Q28214426-2235CE38-3679-4890-B69E-62B34770FEB3

P3181

P356

P1433

P1476

Activation of peroxisome proli ...... mall cell lung carcinoma cells

@en

P2093

Hideki Hoshino

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shimizu

http://www.w3.org/2001/XMLSchema#string

Kaoru Miyamoto

http://www.w3.org/2001/XMLSchema#string

Masanabu Yamada

http://www.w3.org/2001/XMLSchema#string

Masanobu Yamada

http://www.w3.org/2001/XMLSchema#string

Masatomo Mori

http://www.w3.org/2001/XMLSchema#string

Matsumoto Mori

http://www.w3.org/2001/XMLSchema#string

Mitsuo Toyoda

http://www.w3.org/2001/XMLSchema#string

Teturou Satoh

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Monden

http://www.w3.org/2001/XMLSchema#string

P2860

Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

Isolation, characterization and chromosomal localization of the human GADD153 gene

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

P2888

P304

2171-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3653236

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1205279

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11419029

http://www.w3.org/2001/XMLSchema#string

P6179

1048159975

http://www.w3.org/2001/XMLSchema#string

P698

11948400

http://www.w3.org/2001/XMLSchema#string

P921